US supplements company reports sales loss
in net sales for the third quarter ended September 30, 2001.
US supplements company Whitewing Labs, Inc. announced a reduction in net sales for the third quarter ended September 30, 2001. Sales decreased to $148,658 (168,862 euros) from $187,375(212,841 euros) reported for the third quarter of 2000. The net loss for the third quarter of 2001 was $139,063 (157,963 euros), or $0.02 (0.027euros) per share versus the 2000 third quarter loss of $90,858(103,206 euros), or $0.03 (0.034 euros) per share. Net loss for the first nine months of 2001 was $338,604 (384,624 euros), or $0.07 (0.079 euros) per share, versus the 2000 first nine months loss of $222,750 (253,024 euros) or $0.08 (0.098 euros) per share. The company did not comment on the results. Whitewing Labs, Inc. is a publicly held company that develops and markets nutritional supplements.
